Convergent Ventures

Celebrating Excellence in Science and Innovation   NanoVation Therapeutics is proud to share an incredible milestone for its leadership team. Clarivate revealed the Highly Cited Researchers 2024 List (read more here: https://sl8.in/pQD2klVe), recognizing the world’s most influential scientists—and we are thrilled to see our own leaders included.   Dominik Witzigmann, PhD, CEO, Pieter Cullis, Board Chair, and Jayesh Kulkarni, CSO  have been recognized for their exceptional contributions to science and their profound impact on the global research community.    💡This accomplishment not only highlights their individual expertise but also reflects the scientific strength of NanoVation Therapeutics’ mission to develop innovative technologies that overcome the barriers to nucleic acid delivery, addressing some of the most pressing healthcare challenges.   NTx continues to push the boundaries of innovation, and this is only the beginning. Follow this page for more updates as the company builds on its mission to shape the future of healthcare.   #NanoVationTherapeutics #Innovation #Biotech #GeneticMedicine #RNA #LNP #NucleicAcids

A huge congratulations to our portfolio company FibreCoat on successfully closing their $20M Series B funding round! 🎉 This is a major milestone, well-deserved. The round is co-led by by NewSpace Capital and GOOSE Capital. FibreCoat's founders Robert Brüll, Richard Haas and Alexander Lüking have demonstrated exceptional resilience over the past three years. They are a perfect example of the type of entrepreneurs we back - whip smart, open, collaborative, resilient, kind, biased toward action, customer-focused, and building an awesome company culture. These down-to-earth guys and gals are headed to space! 🚀 After commercializing in building materials and defense, the team is expanding to space applications. Cheers to the FibreCoat team, here's to a bright future! #SeriesB #FibreCoat #Innovation #AdvancedMaterials #VC #VentureCapital #Space #IndustrialMaterials

Proudly presenting Christina Jenkins, MD, General Partner at Convergent Ventures who will be attending INVEST 2025 and providing her investor perspective as to what's hot and what's not in healthcare investment. Register Now: https://ow.ly/9R2H50UfcxA #mcninvest #investorperspective

This week I attended a pitch and networking event in Boston with the Canadian Technology Accelerators | Accélerateurs technologiques canadiens. This accelerator exists to connect Canada’s most promising tech startups in 7 different tech verticals with partners in the US market.  As an investor I was excited to attend, especially because in Climatetech (the focus of this cohort) Canada has a wealth of critical mineral resources that are key to electrification if they can be harnessed efficiently and responsibly. So I was especially interested in what Dustin Angelo of Novamera Inc. is creating in new precision mining technologies. I also enjoyed the ‘fireside’ chat that Andrew Maker hosted with Kyle Teamey (see photo). The discussion covered thoughts on navigating the many nuances of the permitting process in the US, what is the mindset needed for building a real business, will IPOs come back (maybe yes!), and much more. Convergent Ventures #Canada #ClimateTech #Startups #cleantech #innovation

Excited to announce the beta release of our BIOTIA-DX Influenza Pipeline! This powerful tool provides H and N typing, H5 sub-clade analysis, and cleavage site detection from assembled genomes. It’s designed to give researchers detailed insights into influenza genomics, supporting surveillance and research efforts. We’re also working on exciting new features like recombination detection and pathogenicity scoring. If you’re interested in using the beta tool let us know!

The Convergent Ventures team is so excited to announce our investment in NanoVation Therapeutics™. Dominik Witzigmann, PhD and his team are developing Lipid Nano Particles (LNPs), essentially carriers that enable the delivery of mRNA drugs where they are needed most in the body. Our very own Zach Jonasson is representing Convergent on the Board, and is joined by David Main - together they bring decades of experience building and scaling successful biotechnology companies through strategic collaborations and technology development. Go NanoVation Therapeutics™! #LNP #GeneticMedicines #NucleicAcid #VentureCapital

"There’s an immense opportunity to bridge the gap between the incredible innovation landscape at Northwestern University and the marketplace," said Phil Carter, Director of Strategic Alliances at the Innovation and New Ventures Office (INVO) Carter will support the newly launched Trienens-Q Cleantech Accelerator Program to cultivate collaboration and take Northwestern entrepreneurs from discovery to commercialization of ideas for a more sustainable future. The Trienens-Q Cleantech Accelerator & Entrepreneurship event last week gathered cleantech industry experts, faculty, postdoctoral scholars, and graduate students for a panel discussion, startup success stories, and networking. Panelists Ben Schlatka from Material Impact, Shashank Churukanti from Evergreen Climate Innovations, and Gami Dadusc Maislin from Convergent Ventures shared insights from their experience developing an impressive portfolio of cleantech startups.    More about the event: https://lnkd.in/dGPy9ZB5 Lisa Dhar | Sonia Kim | Yosi Kratish | Farley Center for Entrepreneurship and Innovation | Northwestern's Querrey InQbation Lab | Northwestern University - Kellogg School of Management #entrepreneurship #cleantech #startup #innovation #plastic #sustainability

What a fantastic event last night in Berkeley. Thanks, Canary Media Inc. for putting it together! The program included a review of climate wins (and losses) at the state and local levels from last week's election, outlining where and how measures related to climate mitigation and adaptation can occur. We also heard from journalists, local and state representatives from CA on the progress done and on the challenges ahead facing electrification so it benefits all communities. It was good to hear concrete ideas to break some of those barriers and shake up how energy can be generated, transmitted, distributed, and paid for!

Biotia Gets First-Ever NY State Regulatory Approval for a Urine Infectious Disease Test Powered by Genomics and AI We are thrilled to share big news at Biotia! After years of development and regulatory review, our BIOTIA-ID Urine NGS Assay has received New York State Department of Health regulatory approval! This is a major milestone for Biotia, as well as clinicians and patients seeking cutting-edge UTI tests which are more informative and accurate. This is especially important for patients suffering from recurrent or complicated UTIs. More about the test: - Unmatched Accuracy: 97% sensitivity and 99% specificity, far surpassing traditional methods. - AI-Powered: Our advanced machine learning algorithms deliver rapid and precise results. - Comprehensive: Identifies a broader range of pathogens, including those often missed by culture. Learn more about BIOTIA-ID and its potential to transform UTI diagnostics: https://lnkd.in/emQGZy6w #UTI #diagnostics #womenshealth #precisionmedicine #AI #innovation #healthcare

I was honored to represent Convergent Ventures as a panelist yesterday at Northwestern's Querrey InQbation Lab and the Paula M. Trienens Institute for Sustainability and Energy discussing Entrepreneurship Opportunities and Challenges alongside Shashank Churukanti and Ben Schlatka. The audience of students and faculty asked such great questions that the time flew by! Northwestern University has been quite obviously hard at work developing out their entrepreneurial ecosystem - they are in the Pitchbook top 10 University graduate programs churning out founders globally - you should definitely check them out if you're interested in new startups developing new technologies. And shout out to the smart and energetic leadership team: Lisa Dhar, Sonia Kim, Phil Carter! #sustainability, #entrepreneurship, #startups, #venturecapital, #cleantech, #Northwestern